Vimta Labs' consolidated net profit surged 44.91% to Rs 11.68 crore on a 14.77% jump in revenue from operations to Rs 67.34 crore in Q3 FY22 over Q3 FY21.
Consolidated profit before tax (PBT) rose 45.53% to Rs 15.47 crore in Q3 FY22 from Rs 10.63 crore in Q3 FY21.
On a standalone basis, Vimta Labs' net profit surged 44.31% to Rs 11.56 crore on a 14.60% increase in revenue from operations to Rs 66.68 crore in Q3 FY22 over Q3 FY21.
Vimta Labs provides services of testing and contract research in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies. It supports regulatory authorities in mandatory certification of food and agricultural products exported from India.
Shares of Vimta Labs lost 0.59% to Rs 427.30 on BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
